The National Institutes of Health (NIH) has announced a major policy shift ending the use of human fetal tissue in all NIH-supported research.
Effective immediately, taxpayer dollars will no longer fund research using tissue from elective abortions, reflecting a move toward modern scientific alternatives such as organoids, tissue chips, and computational biology.
NIH Director Jay Bhattacharya emphasized that the change advances biomedical science while upholding ethical standards and the values of the American people. The policy applies to all intramural and extramural NIH research, ensuring public resources are directed toward next-generation models that improve health outcomes without relying on human fetal tissue.
More details here.